Status:
TERMINATED
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a study to evaluate the effectiveness of an investigational drug in patients with cancer of the lung.
Eligibility Criteria
Inclusion
- Patients who are at least 18 years of age with cancer of the lung and who have had either no previous treatment or 1 previous treatment for advanced cancer of the lung. Certain other treatments may also be allowed (prior cytotoxic chemotherapy in the adjuvant setting)
Exclusion
- Patients who have had treatment with any investigational therapy within the past 30 days are not eligible.
- Patients who have had a disease or medical condition that is not controlled will not be eligible.
- Patients who are pregnant or breastfeeding are not eligible.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00290550
Start Date
June 1 2006
End Date
May 1 2007
Last Update
July 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.